Andere Sprachen Biogen Inc. Sao Paulo

Aktien

BIIB34

BRBIIBBDR001

BIIB34

Verzögert Sao Paulo Andere Börsenplätze 16:25:03 25.04.2024			% 5 Tage	% 1. Jan.
171.4 ^BRL	-2.16%		-.--%	-16.49%

22.05.	MÄRKTE USA/Etwas leichter - Fed weiter besorgt über hohe Inflation	DJ
22.05.	US-Aktienmärkte schließen am Mittwoch niedriger, nachdem das Sitzungsprotokoll der Fed Inflationssorgen aufkommen lässt	MT

Andere Sprachen

Schalten Sie alle Nachrichten frei: Seien Sie als Erster informiert und reagieren Sie vor den Märkten!

100% kostenlose Registrierung

Biogen : “LEQEMBI®” (Lecanemab) Approved for the Treatment of Alzheimer’s Disease in South Korea	01:45
BIIB Bronstein, Gewirtz & Grossman LLC Announces that Biogen Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!	24.05.
Kirby McInerney LLP Announces the Filing of a Securities Class Action on Behalf of Biogen Inc. (BIIB) Investors	24.05.
BIIB Bronstein, Gewirtz & Grossman LLC Announces that Biogen Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!	24.05.
SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Biogen Inc. with Losses to Contact the Firm	24.05.
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Biogen	23.05.
Biogen Bolsters Late-Stage Pipeline, Expands Immunology Portfolio with Agreement to Acquire Human Immunology Biosciences	23.05.
BIIB INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that Biogen Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit	23.05.
Pomerantz Law Firm Announces the Filing of a Class Action Against Biogen Inc. and Certain Officers - BIIB	23.05.
US Equity Markets Close Down Wednesday After Fed Minutes Raise Inflation Concerns	22.05.
Sector Update: Health Care Stocks Slightly Higher Late Afternoon	22.05.
Sector Update: Health Care Stocks Advance Wednesday Afternoon	22.05.
Sector Update: Health Care	22.05.
Biogen Agrees to Buy Human Immunology Biosciences For up to $1.8 Billion	22.05.
Top Midday Stories: US Targets August 1 Start Date for China Tariff Hikes; CFPB Says BNPL Requires Credit Card-Level Oversight; Target Shares Fall on Earnings Miss; Third BHP Bid Rejected by Anglo American	22.05.
Biogen : accord pour l'acquisition de HI-Bio	22.05.
Biogen rachète HI-Bio pour un montant pouvant atteindre 1,8 milliard de dollars	22.05.
Biogen to Acquire Human Immunology Biosciences for up to $1.8 Billion	22.05.
Biogen to buy Human Immunology Biosciences in up to $1.8 billion deal	22.05.
Biogen Bolsters Late-Stage Pipeline, Expands Immunology Portfolio with Agreement to Acquire Human Immunology Biosciences	22.05.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Biogen Inc. Sao Paulo

Aktien

BIIB34

BRBIIBBDR001

BIIB34

Andere Sprachen

Filter